The Global Phenylalanine Market is projected to expand from USD 585.54 Million in 2025 to USD 746.04 Million by 2031, registering a CAGR of 4.12%. Phenylalanine serves as an essential amino acid and a precursor to tyrosine, playing a vital role in the biosynthesis of neurotransmitters such as dopamine and norepinephrine. The market is primarily propelled by strong demand for the artificial sweetener aspartame, a key ingredient in low-calorie food and beverage items. Furthermore, the pharmaceutical industry utilizes the compound to treat conditions like depression and vitiligo, while the animal nutrition sector employs it to enhance protein synthesis in livestock feed, solidifying these industries as the core drivers of sustained market demand.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 585.54 Million
Market Size 2031	USD 746.04 Million
CAGR 2026-2031	4.12%
Fastest Growing Segment	L-Phenylalanine
Largest Market	North America

However, market growth encounters significant hurdles due to supply chain concentration and geopolitical dependency, which expose stakeholders to risks regarding availability and pricing volatility. This vulnerability is intensified by the heavy reliance of major economies on specific manufacturing hubs for raw materials. For instance, the Institute for Feed Education and Research reported that in 2024, the United States depended on China for roughly 62% of its amino acid production needs. Such centralized manufacturing capacity creates distinct risks for the phenylalanine market, as trade disruptions or regulatory changes in the dominant production region could trigger immediate supply shortages.

Market Driver

The Global Phenylalanine Market is significantly driven by the surging global demand for low-calorie aspartame sweeteners, as this amino acid acts as a primary precursor for aspartame production. Driven by increasing health awareness and sugar taxation policies, beverage manufacturers are aggressively expanding their zero-sugar portfolios, thereby boosting the industrial requirement for high-purity phenylalanine. This trend is evident in the strong uptake of sugar-free offerings by major players; for example, The Coca-Cola Company reported in October 2025 that its Coca-Cola Zero Sugar line achieved a 14% volume increase during the third quarter, highlighting the critical role of aspartame-based formulations in stimulating upstream ingredient consumption.

Simultaneously, the market is supported by the growing adoption of high-quality animal feed additives, where phenylalanine is utilized to optimize protein synthesis and improve feed conversion ratios. As the agricultural sector adopts precision nutrition to minimize environmental impact, including essential amino acids in feed has become standard practice for ensuring food security. According to Alltech, global feed production rose by 1.2% in 2024 to reach 1.396 billion metric tons by May 2025, establishing a stable foundation for additive demand. Reflecting the sector's massive scale, The Korea Economic Daily noted in December 2024 that CJ CheilJedang's bio division was expected to exceed 4 trillion won in annual revenue, underscoring the substantial economic value generated by amino acid production for animal nutrition.

Market Challenge

The concentration of supply chains and geopolitical dependency presents a formidable obstacle to the growth of the Global Phenylalanine Market. This vulnerability impedes expansion by creating a single point of failure where localized disruptions-ranging from regulatory shifts to logistical bottlenecks-can cascade into immediate global shortages. Since phenylalanine production is heavily consolidated within limited geographic regions, the market lacks the manufacturing redundancy required to absorb shocks. Consequently, downstream sectors such as the food and beverage industry, which rely on the compound for aspartame, face unpredictable procurement cycles and extreme pricing volatility, forcing companies to operate defensively and limiting their ability to scale or innovate due to raw material insecurity.

The extent of this manufacturing monopolization places global stakeholders in a precarious position regarding inventory security. According to the American Feed Industry Association, in 2025, China controlled approximately 77% of the global supply for lysine and 91% for threonine, indicating a systemic centralization across the amino acid sector that mirrors the landscape for phenylalanine. This overwhelming dominance by a single manufacturing hub means that global pricing structures are often dictated by one nation's policy decisions rather than organic supply and demand mechanics. Such profound dependency discourages long-term capital investment from international buyers who view the lack of alternative supply sources as an unmanageable operational risk, thereby stifling overall market growth.

Market Trends

The pharmaceutical sector is increasingly utilizing phenylalanine as a critical building block for synthesizing novel peptide drugs, moving beyond its traditional role as a simple excipient. This trend is largely fueled by the explosive demand for peptide-based therapeutics, particularly GLP-1 receptor agonists used in diabetes care and weight management, which rely on precise amino acid sequences for efficacy. As these complex biologics capture more market share, the need for high-purity phenylalanine for peptide synthesis has surged to support upstream drug development. Neuland Labs noted in a September 2024 article on peptide trends that clinical trials for obesity drugs increased by 68% in 2023, signaling a robust trajectory for amino acid consumption in this high-value segment.

Concurrently, manufacturers are shifting from chemical synthesis to advanced microbial fermentation processes, which offer higher yield efficiency and improved sustainability profiles. This transition allows producers to mitigate the environmental impact of traditional petrochemical methods while scaling operations to meet global needs. Industry players are investing heavily in new infrastructure to support this bio-based production model, securing raw material access and reducing costs through vertical integration. For instance, Interfax reported in November 2024 that Fufeng Group plans to invest up to USD 350 million to establish a vertically integrated industrial park in Kazakhstan for corn processing and amino acid bio-fermentation, highlighting the significant capital flow into modernizing manufacturing capabilities.

Key Market Players

Ajinomoto Co., Inc.
DAESANG
Livzon
KYOWA HAKKO BIO CO., LTD
Amazing Nutrition
AMINO GmbH
Wuxi Jinghai Amino Acid Co., Ltd
Shijiazhuang Jirong Pharmaceutical Co., Ltd
Shijiazhuang Haitian Amino Acid Co., Ltd

Report Scope

In this report, the Global Phenylalanine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Phenylalanine Market, By Type

L-Phenylalanine
D-Phenylalanine
DL-Phenylalanine

Phenylalanine Market, By Application

Depression
Attention Deficit Disorder
Parkinson disease
Chronic Pain
Vitiligo
Others

Phenylalanine Market, By End-Users

Food and Beverage
Dietary Supplements
Pharmaceuticals
Others

Phenylalanine Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Phenylalanine Market.

Available Customizations:

Global Phenylalanine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Phenylalanine Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (L-Phenylalanine, D-Phenylalanine, DL-Phenylalanine)
- 5.2.2. By Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic Pain, Vitiligo, Others)
- 5.2.3. By End-Users (Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2025)
5.3. Market Map

6. North America Phenylalanine Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By End-Users
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Phenylalanine Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By End-Users
- 6.3.2. Canada Phenylalanine Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By End-Users
- 6.3.3. Mexico Phenylalanine Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By End-Users

7. Europe Phenylalanine Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By End-Users
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Phenylalanine Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End-Users
- 7.3.2. France Phenylalanine Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End-Users
- 7.3.3. United Kingdom Phenylalanine Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End-Users
- 7.3.4. Italy Phenylalanine Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By End-Users
- 7.3.5. Spain Phenylalanine Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By End-Users

8. Asia Pacific Phenylalanine Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By End-Users
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Phenylalanine Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End-Users
- 8.3.2. India Phenylalanine Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End-Users
- 8.3.3. Japan Phenylalanine Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End-Users
- 8.3.4. South Korea Phenylalanine Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End-Users
- 8.3.5. Australia Phenylalanine Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End-Users

9. Middle East & Africa Phenylalanine Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By End-Users
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Phenylalanine Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End-Users
- 9.3.2. UAE Phenylalanine Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End-Users
- 9.3.3. South Africa Phenylalanine Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End-Users

10. South America Phenylalanine Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By End-Users
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Phenylalanine Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End-Users
- 10.3.2. Colombia Phenylalanine Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End-Users
- 10.3.3. Argentina Phenylalanine Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End-Users

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Phenylalanine Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Ajinomoto Co., Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. DAESANG
15.3. Livzon
15.4. KYOWA HAKKO BIO CO., LTD
15.5. Amazing Nutrition
15.6. AMINO GmbH
15.7. Wuxi Jinghai Amino Acid Co., Ltd
15.8. Shijiazhuang Jirong Pharmaceutical Co., Ltd
15.9. Shijiazhuang Haitian Amino Acid Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

SELECT AN OPTION